Pharma & BiotechOntology mapping and rule-based outcome labelingapplied research workflow demonstrated in the study; operational deployment would require robust coding and terminology-mapping pipelines.

Automated SAE label construction from trial reports and clinical coding systems for RWD analysis

Take side effects reported in a clinical trial, translate them into the medical codes used in health records, and mark which patients had serious side effects like hospitalization or death.

9.5

Quality
Score

Executive Brief

Business Problem Solved

Premium content - unlock to see the business problem analysis...

Value Drivers

Value Driver 1Value Driver 2

Strategic Moat

Premium content - unlock to see strategic analysis...

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Pharmaceuticalsbiotech — $499/yr Atlas Pro — $1,499/yr

Executive Brief•Technical•Market Signal

Technical Analysis

Model Strategy

Premium content...

Data Strategy

Premium content...

Implementation Complexity

Premium content...

Scalability Bottleneck

Premium content...

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Pharmaceuticalsbiotech — $499/yr Atlas Pro — $1,499/yr

Executive Brief•Technical•Market Signal

Market Signal

Adoption Stage

Premium content...

Differentiation Factor

Premium content...

Key Competitors

Company ACompany B

Premium Access

Full Analysis Available

Executive brief, technical architecture, and market positioning for this use case.

Pharmaceuticalsbiotech — $499/yr Atlas Pro — $1,499/yr

Executive Brief•Technical•Market Signal

Part of Application

Pharma Evidence Intelligence Suite

10 use cases in this application

Explore More

More in Pharma & Biotech→More Ontology mapping and rule-based outcome labeling→

Source

https://www.nature.com/articles/s41598-023-27856-1